with ketamine and xylazine. For each intravitreal injection, the micropipette was inserted in peripheral retina, just behind the ora serrata, and was deliberately angled to avoid damage to the lens. In situ hybridization was used to show the knockdown effects of AAV-Cre for individual floxed genes. For example, images in fig. S12 showed that the PTEN mRNA signals in the GCL are dramatically reduced at 2 weeks after injection with AAV-Cre but not AAV-GFP. Thus, two weeks following viral injection, the left ON was exposed intraorbitally and crushed with jeweler's forceps (Dumont #5; Roboz)
for 5 seconds approximately 1 mm behind the optic disc. To preserve the retinal blood supply, care was taken not to damage the underlying ophthalmic artery. After the surgical procedure, mice received a subcutaneous injection of buprenorphine (0.05 mg/kg, Bedford Lab) as post-operative analgesic. Eye ointment containing atropine sulphate was applied preoperatively to protect the cornea during surgery. The completeness of optic nerve transection was verified by the demonstrations that after lesion both retrograde and anterograde tracers fail to reach the retina or the superior colliculus (SC), respectively (figs. S13A and S13B).
AAV:
For making AAVs, the cDNA of Cre or GFP was inserted downstream of the CMV promoter/β-globin intron enhancer in the plasmid pAAV-MCS (Stratagene), containing the AAV2 inverted terminal repeats and a human growth hormone polyA signal. pAAV-RC (Stratagene) that encodes the AAV2 genes (rep and cap) and the helper plasmid (Stratagene) that encodes E2A, E4 and VA were used for co-transfection in 293T cells to generate recombinant AAV. Vectors were packaged, concentrated and tittered as described previously (S2) . Control AAV-GFP was generated in an identical fashion. The titers determined by dot blotting as described (S3) are in the range of 0.5-1.0 x 10 12 .
RGC axon anterograde labeling: To identify RGC axons in the optic nerve by anterograde labeling, l µl of cholera toxin β subunit (CTB) (2 µg/µl, Invitrogen) was injected into the vitreous with a Hamilton syringe (Hamilton). Animals were fixed by perfusion with 4% paraformaldehyde (PFA), 0.1 M phosphate buffered saline (PBS), 2 days after CTB injection in the eye.
Labeling of axon-regenerating RGCs: 14 days after intraorbital optic nerve (ON) crush, the left ON was re-exposed. Mice were anesthetized and placed in a stereotaxic holder. Small portions of bones over the frontal sinus and the orbit were removed. After exposure of left ON through a superior temporal intraorbital approach, we slowly injected (at an infusion speed of 2.5 nL per minute), a tiny amount of BDA (10 nL, 10 k MW)-Fluoro-Ruby (Millipore), into the optic nerve region approximately 2.0 to 2.5 mm distal to the lesion site, by using a pulled-glass micropipette attached to an automated Nano-injector. Several pieces of Gelfoam were used to secure the nerve and to fill the cavity. The skin over the orbit was sutured with 6-0 nylon, and buprenorphin was administered subcutaneously at the end of the surgery as post-operative analgesic. At 24 hr post-injection, the animals were perfused and the whole-mount retinas dissected for BDA staining and immunohistochemistry with anti-p-S6 antibodies.
Preparation for histology and immunohistochemistry: Animals were given a lethal overdose of anesthesia and perfused with 4% PFA. For the animals with an optic nerve injury, eyes with the nerve segment still attached were dissected out and post-fixed in the same fixative overnight at 4°C. Tissues were cryoprotected through increasing concentrations of optimal cutting temperature compound (Tissue Tek). Eyes were snapfrozen in dry ice and serial cross-sections (16 µm) were cut and stored at -20°C until processed. Optic nerves were cut longitudinally (8 µm). In a series of mice subjected to intravitreal CTB injection 1 day after optic nerve injury, brains were dissected 3 days after crush and serial coronal sections (40 µm) containing superior colliculi were collected to confirm the reliability of completeness of the crush. BDA staining was performed by incubating the retina in PBS containing streptavidin-HRP (1:200, PerkinElmer). The remaining staining procedure was performed according to the protocol provided by TSA™-plus Cyanine 3 system (PerkinElmer).
Counting regenerating axons:
Regenerating RGC axons in injured optic nerves distal to the crush site were quantified as described previously (S5) . For each animal the number of CTB labeled axons was estimated by counting the number of CTB-labeled fibers extending different distances from the end of the crush site in 5 sections (every 4 th section) per animal. The cross-sectional width of the nerve was measured at the point at which the counts were taken and was used to calculate the number of axons per millimeter of nerve width. The number of axons per millimeter was then averaged over all sections. Σa d , the total number of axons extending distance d in a nerve having a radius of r, was estimated by summing over all sections having a thickness t (8 µm):
Drug handling and administration: Rapamycin was handled and administered as described previously (S6) . Rapamycin was obtained from LC Laboratories, dissolved at 20 mg/ml in ethanol. Before each administration, rapamycin was diluted in 5% Tween 80, 5% polyethylene glycol 400 (0.5-1.5 mg/ml). Rapamycin at 6 mg/kg or the vehicle (5% Tween 80, 5% polyethylene glycol 400 in PBS) was given intraperitoneally at the time AAV-Cre injection every 2 days.
RGC purification and q-PCR:
For retrograde labeling of RGCs for FACS sorting, the superior colliculi of adult Sprague-Dawley rats were injected with DiI (2% in DMF).
Rats were anesthetized and placed in a stereotaxic holder. Approximately 2 µL DiI was then injected directly into the superficial SC (6 mm caudal to Bregma, 1.5 mm lateral to sagittal suture and 4 mm deep to brain surface) via a pulled-glass micropipette attached to an automated nano-injector. 5-7 days after surgery, eyes were removed and retinas were prepared for the cell dissociation procedures. One or three days after crush, retinas were dissected and incubated in digestion solution ( For q-PCR, total RNA (50-100 ng) was reverse transcribed and amplified with TagMan pre-designed real-time PCR assays (Applied Biosystems). Real-time PCR was performed on an ABI 7900HT. Each sample was run in quadruplicate in each assay.
GADPH was used as the endogenous control.
Metabolic labeling: Rat RGCs purified by FACS sorting were incubated in serum-free DMEM lacking methionine and cysteine (Invitrogen) for 30 min at 37°C to deplete intracellular pools of methionine and cysteine. The medium was then changed to prewarmed pulse solution (0.2 mCi/ml 35 S-Met/Cys, PerkinElmer, in serum-free DMEM lacking methionine and cysteine) for another 30 min at 37°C. Reaction was stopped by putting cells on ice and spinning at 5000 g for 5 min, 4°C. Cells were washed with icecold PBS twice before lyzed in RIPA buffer (50 mM Tris, pH 8.0, 150 mM NaCL, 1%
NP-40, 0.5% sodium deoxycholate, 5 mM sodium pyrophosphate, 0.05 mM sodium fluoride, 1 mM sodium orthovanade and complete protease inhibitor cocktail from Roche). Equal amounts of protein extract were loaded into 10% SDS-PAGE gels. The gels were stained with SYPRO Ruby fluorescent dye (Invitrogen) to confirm the equal loading before fixed, dried and exposed to phosphor storage screen (Molecular Dynamics) for 1-2 days. The images were scanned by Typhoon Trio, analyzed and quantified by ImageQuant 5.0 (GE Healthcare).
In Situ Hybridization: Mouse cDNA sequences for PTEN, TSC1, PI3Kca, PI3Kca2, and PI3Kr1 (Allen Brain Atlas) were subcloned into pBluescript II SK+ (Stratagene). In vitro transcription was performed from linearized plasmids using T7 and T3 RNA polymerase (Promega) with digoxigenin-UTP (Roche) for synthesis of sense and antisense probes, respectively. In situ hybridization was performed following the standard protocols. After hybridization, mRNA localization was detected with APconjugated anti-digoxigenin Fab fragments followed by visualization with NBT/BCIP.
Staining for PLAP activity: Rosa-STOP-PLAP reporter line was a gift by Dr. F.
Wang. Tissue sections were fixed in 4% PFA for 1 hour and incubated at 65°C for overnight in PBS to heat inactivate the endogenous alkaline phosphatase activity.
Sections were then washed with alkaline phosphatase (AP) buffer (100 mM Tris pH 9.5, 100 mM NaCl, 50 mM MgCl 2 ) and developed in AP buffer containing NBT (4.5 µl/ml) and BCIP (3.5 µl/ml) until staining was seen. Sections were dehydrated in increasing concentration of ethanol and cover slipped with Mounting Medium (Richard-Allan Scientific).
X-gal staining:
Rosa26-lox-Neo-lox-LacZ reporter mice (1) injected with AAV-Cre were perfused with 0.2% glutaraldehyde. Retinas were frozen and cryo-sectioned as described above. Sections were post-fixed in 0.2% glutaraldehyde for 20 minutes followed by several washes in PBS. X-gal stock was diluted initially to 50 mg/ml in dimethylformamide and further diluted to 1 mg/ml in X-gal Reaction Buffer (35 mM potassium ferrocyanide, 35 mM potassium, 2 mM MgCl 2 0.02% Nonidet P-40 (NP-40, 0.01% Na deoxycholat). Slides were stained in X-gal Reaction Buffer, for 1-24 hours at (A and B) Optic nerve sections with CTB-labeled axons (green) and immunostained for a macrophage marker CD68 (red) showing infiltrated macrophages and axonal sprouts in the lesion sites at 3 or 7 days post-injury. More axonal sprouts penetrating into the macrophage-infiltrated lesion sites were seen in PTEN f/f but not in wild type mice. Scale bar, 20 µm. n=3 in each group. (C to F) Electron microscopic photographs of optic nerves from PTEN f/f with AAV-Cre and wild type mice at 3 (C and D) or 7 (E and F) days post-injury. Images were taken from the optic nerves distal to the lesion site, which was identified by the infiltrated macrophages (+). In each panel, the box within the images on the left side is shown in high magnification on the right. The remnants of myelin debris were seen in both wild type (C and E) and PTEN deleted (D and F) mice. But the axoplasm of axonal sprouts containing microtubules (arrows) in a well-ordered array in PTEN f/f /AAV-Cre mice (D and F). Denuded axons with regular close spacing and in bundles characteristic of axonal sprouts were prominent at 3 (D) and 7 days (F) post injury in PTEN deleted animals. *: Crush site. Scale bars, 0.5 µm. Figure S6 . Scheme of the PTEN/mTOR signaling pathway. In response to receptor tyrosine kinase (RTK) activation, PI3K phosphorylates and converts the lipid second messenger phosphatidylinositol (4,5) bisphosphate (PIP 2 ) into phosphatidylinositol (3,4,5) trisphosphate (PIP 3 ), which recruits and activates phosphatidylinositol-dependent kinase 1/2 (PDK1/2). PDK1/2, in turn, phosphorylates and activates Akt. PTEN catalyzes the conversion from PIP 3 to PIP 2 . Thus, inactivation of PTEN results in the accumulation of PIP 3 and the activation of the Akt. Akt controls a host of signaling molecules, including TSC1/2. Downstream of the TSC1/2 complex lays mTOR, which integrates various cellular signals including nutrient availability to control protein translation, cell growth, and other processes. The ribosomal protein S6 kinase (RP-S6) and the eukaryotic initiation factor 4E (eIF-4E) binding protein 1 (4E-BP1) are the mTOR effector molecules executing these functions. Cellular stresses such as hypoxia induce expression of Redd1/2, which augments TSC1/2 activity and in turn suppress the mTOR activity. Figure S7 . Purification of RGCs. (A) Representative image of flat-mounted retina showing RGCs with retrograde labeled DiI. Scale bar, 100 µm. For retrograde labeling of RGCs, anesthetized rats placed in a stereotaxic holder were injected with 2µL 2% DiI into the superficial superior colliculus (6 mm caudal to Bregma, 1.5 mm lateral to sagittal suture and 4 mm deep to brain surface) via a pulled-glass micropipette attached to an automated nano-injector. 5-7 days after surgery, eyes were removed and retinas were prepared for the cell dissociation procedures. (B) Dissociated retinal cells with DiI labeled RGCs. One or three days after crush, retinas were dissected out and incubated in digestion solution (20 U/ml papain, Worthington; 1 mM L-cysteine HCL; 0.004% DNase; 0.5 mM EDTA in Neurobasal) for 25-30 min at 37°C, with gentle shaking every 5 min. Digestion was stopped by adding Ovomucoid/BSA (1 mg/ml) solution before trituration with trituration buffer (0.5% B27; 0.004% DNase; 0.5 mM EDTA in Opti-MEM). For q-PCR, total RNA (100 ng) was reverse transcribed and amplified using TagMan pre-designed real-time PCR assays (Applied Biosystems). Real-time PCR was performed on an ABI 7900HT. Each sample was run in quadruplicate in each assay. GADPH was used as the endogenous control. (A and B) mRNA levels of indicated genes were measured using qPCR and normalized against GADPH. CL: contralateral. *: p <0.01, paired Student's t-test. + cells among total TUJ1
+ cells in the GCL of each retina. Cell counts were performed on at least 6 non-consecutive sections, from three mice per age group. *: p < 0.001, Student's t-test. 
